The connection between cardiovascular disease (CVD) and diabetes has long been established, with CVD being the #1 cause of death in people with diabetes globally. Diabetes affects 30.3 million Americans and more than a third are at elevated risk for CVD.
A new clinical trial recently looked at whether patients who are at risk of a cardiovascular event would benefit from a prescription medication known as icosapent ethyl. This study found icosapent ethyl reduced the risk of total ischemic events (e.g., stroke and heart attack) by 30%.
Now, the American Diabetes Association (ADA) has addressed this issue in its updated standard of medical care in diabetes. Talk with your doctor or click here for more information.